A. Raza
Rush Cancer Institute and the Departments of Pathology and Biostatistics
Rush-Presbyterian-St. Luke's Medical Center
Chicago
IL 60612-3515
USA
Name/email consistency: high
- Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Raza, A., Meyer, P., Dutt, D., Zorat, F., Lisak, L., Nascimben, F., du Randt, M., Kaspar, C., Goldberg, C., Loew, J., Dar, S., Gezer, S., Venugopal, P., Zeldis, J. Blood (2001)
- Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Raza, A., Qawi, H., Lisak, L., Andric, T., Dar, S., Andrews, C., Venugopal, P., Gezer, S., Gregory, S., Loew, J., Robin, E., Rifkin, S., Hsu, W.T., Huang, R.W. Blood (2000)
- Myelodysplastic syndromes may have an infectious etiology. Raza, A. J. Toxicol. Environ. Health Part A (2000)